Category: Healthcare

Healthcare

Ortho k Lens Market | Know the Latest Innovations in the Market

Orthokeratology (ortho-k) lens has gathered traction in corrective procedures, preferred mainly to correct myopia in children. These lenses are used to recontour cornea. The specially designed lens have emerged as an alternative to vision surgeries and contact lens, the options that are not recommended clinically or not a pragmatic approach. Growing incidence of refractive errors in worldwide population is a key driver foe demand in the ortho-k lens market. A growing percentage of people who have undergone contact lenses fitting operations have adopted ortho-lens, which is a key aspect that echoes the attractiveness of the market.

Get Sample Copy of this Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7321

A growing body of studies has dealt in making an in-depth assessment of the safety profile and predictability of ortho-k lens in short-sightedness. A sizable chunk of sales in the ortho-k lens have occurred in semi-tropical countries over the past few years. Young adults have become increasingly drawn toward the convenience of using the ortho-k lenses and their supposed effectiveness. However, clinical evidence is inconclusive at large. Nonetheless, the expanding science keeps imparting momentum to lens-induced corneal reshaping.

Overnight Use Gathering Traction

Numerous factors have limited the adoption of products in the ortho-k lens. For one, visual gain is hard to predict due to in poor fitting and risk of microbial keratitis. Semi-tropical environments makes the lenses prone to microbial growth, severely impacting the efficacy in some cases. High incidence of microbial keratitis among wearers has confirmed the conjecture.

In recent years, overnight use of ortho-k lens has gained substantial steam among the users. In some regional studies, such as by the  American Academy of Ophthalmology the lens type has been found to be effective for myopia control. For instance, ortho-k lens has been to be effective in correction of astigmatism above 1.75 dioptres and up to 3.50 dioptres. More such studies are needed to confirm the efficacy. On the other hand, new toric designs have come to the fore.

Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7321

Research validates efficacy of world’s first blood test for monitoring cancer treatment in real-time

For patients of cancer undergoing targeted therapy, a new blood test is a breakthrough. The blood test is distinguished that allows doctors to know if the treatment is working, within one day. Due to this remarkable trait, this will help doctors expedite the evaluation process and enable them to make adjustments to the line of treatment if required.

In fact, unlike other predecessor chemotherapies that interfere with all rapidly multiplying cells and can cause massive damage to cells, targeted medicines work exactly the opposite. Targeted medicines attack specific molecules to block the abnormal growth of cancer cells.

Meanwhile, currently, the clinical evaluation of targeted drugs primarily is dependent on either tumor volumetric imaging or invasive tissue biopsies. To expand the use of targeted drugs, a team of researchers at the National University of Singapore have developed an accurate, less invasive technology that uses liquid biopsies, thus, significantly forwards the investigation window.

The technique is the world’s first of its kind. The technique takes advantage of extracellular vesicles secreted by cancer cells, and circulates it in the blood as an indicator of effectiveness of drugs in solid tumors.

Importantly, conventional procedures such as tumor imaging are expensive and are also delayed. The effectiveness of these treatments can be gauged only after weeks. On the other hand, use of the new technique enables to directly measure outcomes of effectiveness of drugs within 24 hours of initiation of the treatment. This is presumed to significantly reduce the cost and time for monitoring of cancer treatment.

Besides this, the technique requires only a small amount of blood sample for analysis and each requires less than an hour to complete.

Healthcare Patent Filing Outsourcing Market to Gain Massive Thrust from Cost-reduction Measures

Healthcare is in throes on innovation, spearheaded by digital technologies. Medtech companies have rebuffed their efforts in becoming a part of the digital transformation narrative the developed world has charted. They are keenly growing patent filing in Europe and North America. Rise in demand for patent filing for new pharmaceutical and biotechnology products has been a key trend in recent years. Despite the unprecedented growth of patent filing in some developed nations of the regions, healthcare companies have been increasingly pressurized to cut in cost, squeezing their profit margins. The popularity of patent filing outsourcing services has stemmed from this trend, and will continue to make waves for the next few years of this decade.

Get Sample Copy of this Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7323

Asia Emerged as Favorable Hotspot, Startup Culture Imparting Momentum to Services Delivery

Over the past five years, emerging economies, with glaring examples in Asia, have been key destinations for offshore outsourcing of patents. A case in point is India, where the global healthcare patent filing outsourcing has risen remarkably. Further, there is a growing focus on intellectual property rights.

The rise in use of assays is a key trend bolstering the prospective demand for patent filing, thereby spurring the prospect of outsourcing services from numerous Asian nation. Prevalence of chronic diseases and rise in research for novel ingredients in various drug-making activities have propelled patent data to regulatory agencies, such as European Patent Office (EPO) and United States Patent and Trademark Office (USPTO or Office). India has emerged as an attractive outsourcing hub for various business. A number of such companies have cropped up in high-tech cities of the country, with Bangalore being an example. Several trends support the growth of the healthcare patent filing outsourcing in Asian nations. For one, several start-ups offered services have emerged to the fore, where they are doing that for a fraction of overall costs.

Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7323

Fibromyalgia Market | Latest Trends and Cardinal Growth Prospects

Fibromyalgia or fibrositis refers to a severe pain disorder that is identified by tenderness to touch as well as consistent pain. The severity of this health condition is so high that it is known for impacting the mental, social, and physical status of an individual. Generally, fibromyalgia patients deal with various levels of physical symptoms such as intensity, sleep disturbances, cognitive difficulties, and fatigue. In addition to this, many patients face metal health issues including migraines, depression, irritable bladder, and headaches.  

Get Sample Copy of this Report @ https://www.tmrresearch.com/sample/sample?flag=B&rep_id=7333

As per the data from fibroandpain.org, around 10 Mn Americans are dealing with the health condition fibromyalgia. This number depicts the ratio of around 8:2 women over men. This huge number of patient base is one of the key factors fueling prominent demand opportunities for vendors operating in the global fibromyalgia market.

The global fibromyalgia market experiences presence of many active enterprises. Thus to sustain in the high level of competition, players are executing various strategic moves. Some of the key strategies include various alliances, partnerships, collaborations, and joint ventures. In addition to this, many enterprises are pouring investments toward the research and development activities. Main motive of these researches is the development of advanced solutions for the treatment of fibromyalgia. On the back of all these activities, the global fibromyalgia market is estimated to steam extensive expansion avenues in the forthcoming years.

Check Table of Contents of this Report @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=7333

North America: Prominent Market Region for Fibromyalgia Market

On regional front, the fibromyalgia market shows presence across Europe, North America, the Middle East and Africa, and Asia Pacific. Of them, the market is estimated to gather prodigious avenues in North America. This growth of the North America fibromyalgia market can be attributed to many factors including increased awareness regarding the health condition together with the increased cases of arthritis in the region.